Results 121 to 130 of about 2,108 (191)

Correction: One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report. [PDF]

Ophthalmol Ther
Tillmann A, Stillenmunkes R, Garweg JG, Cattaneo J, Bartolomeo N, Grimaldi G, Spitznagel T, De Oliveira Figueiredo EC, Ambresin A, Menghini M, Somfai GM, Zweifel S, Fröhlich J, Artemiev D, Ebneter A, Hatz K, Weinberger A, Pfister IB, Schild C, Eandi C, Munk MR, Swiss Retina Research Network.   +21 more
europepmc   +1 more source

Real-World 6-Month Treatment Outcomes of Faricimab in Turkey: The FARTURK Study. [PDF]

Ophthalmol Ther
Çakır A, Akkan F, Kapran Z, Ünal M, Şerif N, Uzundede T, Karataş G, Öztürk M, Dündar H, Erakgün T, Alp MN, Koçak N, Saatci AO, Çetin EN, Durukan AH, Şahin M, Muhacir F, Yeşiltaş YS, Uyar OM, Emre S, Şekeroğlu MA, Önen M, Bulut M, Karalezli A, Kadayıfçılar S, Özdek Ş, Doğanay S, Kaya M, Öz Ö, Kaderli ST, Avcı R, Şermet F, Demirel S, Küçükerdönmez C, Yıldırım C, İpek ŞC, Ayhan Z, Altan T, Gürelik İG, Görgün E, Yenerel NM, Seymenoğlu G, Vural E, Sül S, Çıtırık M, Özdemir HB, Cömerter D, Karabaş VL, Özdemir H.   +48 more
europepmc   +1 more source

Comparative evaluation of stability, efficacy, and sterility in five repackaged intravitreal anti-vascular endothelial growth factor medications. [PDF]

Sci Rep
Thunwiriya P, Phetruen T, Chaiwijit P, Tonawannakorn C, Dekham K, Thadtapong N, Chaturongakul S, Charoensawan V, Chanarat S, Pakotiprapha D, Hanutsaha P.   +10 more
europepmc   +1 more source

Expert Opinion on the First-Line Management of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in India: The Role of Faricimab. [PDF]

Cureus
Jayadev C, Talwar D, Bhende M, Narayanan R, Gupta V, Chakraborty D, Deka S, Manayath G, Banker A.   +8 more
europepmc   +1 more source

First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report. [PDF]

BMJ Open Ophthalmol
Saad A, Plasencia C, Garweg J, Pfister IB, Munk MR, Eandi CM, Zweifel SA, Grimaldi G, Bartolomeo N, Stillenmunkes R, Schild C, Cattaneo J, Gabathuler F, Menghini M, Ambersin A, Froehlich J, Artemiev D, Weinberger A, Mohamed H, Somfai GM, Hatz K.   +20 more
europepmc   +1 more source

Intravitreal faricimab in patients with refractory diabetic macular edema: 6-month fluid analysis using artificial intelligence. [PDF]

BMC Ophthalmol
Owlya N, Barbosa M, Bartolomeo N, Pannatier-Schuetz Y, Nascimbeni AC, Castro DG, Barry MP, Ambresin A.   +7 more
europepmc   +1 more source

Rapid Fluid Resolution and Durability With Faricimab in Neovascular Age-Related Macular Degeneration.

JAMA Ophthalmol
Pitcher JD, Koh AHC, Tan CS, Vakharia P, Dagincourt N, Patel S, Yang M, Margaron P, Gallego-Pinazo R.   +8 more
europepmc   +1 more source

Intraocular inflammation after intravitreal injection of faricimab-a case series including one case of bilateral choroidal involvement. [PDF]

Int J Ophthalmol
Lischke R, Krause SM, Rauchegger T, Haas G, Koubek M, Nowosielski Y, Rehak M.   +6 more
europepmc   +1 more source

Bilateral hemorrhagic occlusive retinal vasculitis and panuveitis following intravitreal faricimab injection: A clinicopathologic case study. [PDF]

Am J Ophthalmol Case Rep
Yavari N, Gupta AS, Mitsios A, Hung JH, El-Feky D, Nguyen CD, Yasar C, Anover FA, Saengsirinavin AO, Mobasserian A, Akhavanrezayat A, Elaraby O, Zhang X, Than NTT, Toth AB, Agarwal D, Lin J, Or C, Nguyen QD.   +18 more
europepmc   +1 more source

Efficacy of Faricimab in Neovascular Age-Related Macular Degeneration: A Single-Arm Systematic Review and Meta-Analysis. [PDF]

Ophthalmic Res
Karam M, Baeshen M, Alfuzaie R, Mohammad M, Alshatti A, Samet A, Paez-Escamilla M, Sun V.   +7 more
europepmc   +1 more source